Path-breaking Science and Platform
to Power Transformative Therapeutics

Our Drug Development Platform

Our platform is focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences.

We have created a platform and knowledge base that identifies Insulated Genomic Domains (IGDs) and their biological functions in both healthy and diseased states across cell types. IGDs function as the fundamental regulators, or GenomStats™, of the human genome.

This scientific insight drives our discovery and development of genomic modulators called Omega Controllers™, which we engineer to precisely tune genomic activity to desired therapeutic levels without altering the human genetic code. We are developing precision therapeutics for a range of disease indications, including rare genetic diseases, immunology, inflammation, metabolic diseases and oncology.

“OMEGA THERAPEUTICS IS LEVERAGING UNPRECEDENTED INSIGHTS INTO THE HUMAN BODY’S CAPACITY TO UNLOCK NATIVE GENOMIC CONTROL AS A NEW THERAPEUTIC MODALITY” —Flagship Pioneering

RESEARCH BIBLIOGRAPHY

SELECT PUBLICATIONS